1,3-dibromo-4,6-bis(acetamido)benzene
|
- $11 - $474
- Product name: 1,3-dibromo-4,6-bis(acetamido)benzene
- CAS: 132530-67-7
- MF: C10H10Br2N2O2
- MW: 350.01
- EINECS:
- MDL Number:MFCD29035244
- Synonyms:1,3-dibromo-4,6-bis(acetamido)benzene;N,N'-(4,6-Dibromo-1,3-phenylene)diacetamide;Acetamide, N,N'-(4,6-dibromo-1,3-phenylene)bis- (9CI);1,1′-(Butane-1,4-diyl)bis(3-(2-(2-(2-aminoethoxy)ethoxy)ethyl)urea) 2hcl;N,N'-(4,6-Dibromo-1,3-phenylene)diacetamide
4 prices
Selected condition：
Brand
- Ambeed
- Crysdot
Package
- 1g
- 5g
- 25g
- ManufacturerAmbeed
- Product numberA616171
- Product descriptionN,N'-(4,6-Dibromo-1,3-phenylene)diacetamide 97%
- Packaging1g
- Price$11
- Updated2021-12-16
- Buy
- ManufacturerAmbeed
- Product numberA616171
- Product descriptionN,N'-(4,6-Dibromo-1,3-phenylene)diacetamide 97%
- Packaging5g
- Price$36
- Updated2021-12-16
- Buy
- ManufacturerAmbeed
- Product numberA616171
- Product descriptionN,N'-(4,6-Dibromo-1,3-phenylene)diacetamide 97%
- Packaging25g
- Price$137
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD12153683
- Product descriptionN,N'-(4,6-Dibromo-1,3-phenylene)diacetamide 97%
- Packaging1g
- Price$474
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| Ambeed | A616171 | N,N'-(4,6-Dibromo-1,3-phenylene)diacetamide 97% | 1g | $11 | 2021-12-16 | Buy |
| Ambeed | A616171 | N,N'-(4,6-Dibromo-1,3-phenylene)diacetamide 97% | 5g | $36 | 2021-12-16 | Buy |
| Ambeed | A616171 | N,N'-(4,6-Dibromo-1,3-phenylene)diacetamide 97% | 25g | $137 | 2021-12-16 | Buy |
| Crysdot | CD12153683 | N,N'-(4,6-Dibromo-1,3-phenylene)diacetamide 97% | 1g | $474 | 2021-12-16 | Buy |
Properties
Boiling point :513.0±50.0 °C(Predicted)
Density :1.862±0.06 g/cm3(Predicted)
pka :12.60±0.70(Predicted)
Density :1.862±0.06 g/cm3(Predicted)
pka :12.60±0.70(Predicted)
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|